Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Terrance T. Creighton"'
Autor:
Eric C. Kauffman, Charles L. Roche, Michael Petroziello, Craig Hendler, Thomas Schwaab, Kristopher M. Attwood, Christine Murekeyisoni, Daniel Abbotoy, Terrance T. Creighton, Shervin Badkhshan, Bo Xu, Jay Amin
Representative CT imaging of CD117(-) RO/ChRCC tumors using an early contrast phase. (A) This representative CD117(-) RO tumor has relative hyperenhancement (tumor:cortex PEER 0.79) that is similar to CD117(+) RO tumors; (B) Thisrepresentative CD117(
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324924f9467d23e03cc65be89b7e963a
https://doi.org/10.1158/1078-0432.22474721
https://doi.org/10.1158/1078-0432.22474721
Autor:
Eric C. Kauffman, Charles L. Roche, Michael Petroziello, Craig Hendler, Thomas Schwaab, Kristopher M. Attwood, Christine Murekeyisoni, Daniel Abbotoy, Terrance T. Creighton, Shervin Badkhshan, Bo Xu, Jay Amin
Non-PEER CT peak signal intensity/enhancement values in RO versus ChRCC tumors according to CD117 expression. (A) Net peak enhancement using the delayed/excretory contrast phase relative to the unenhanced phase; (B) Absolute peak signal intensity usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25fc0cb257e335488c74a2cabdf5a4ea
https://doi.org/10.1158/1078-0432.22474724
https://doi.org/10.1158/1078-0432.22474724
Autor:
Eric C. Kauffman, Charles L. Roche, Michael Petroziello, Craig Hendler, Thomas Schwaab, Kristopher M. Attwood, Christine Murekeyisoni, Daniel Abbotoy, Terrance T. Creighton, Shervin Badkhshan, Bo Xu, Jay Amin
Purpose: The diagnostic differential for CD117/KIT(+) oncocytic renal tumor biopsies is limited to benign renal oncocytoma versus chromophobe renal cell carcinoma (ChRCC); however, further differentiation is often challenging and requires surgical re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d2d213daebc98faffd6e673e61e54c
https://doi.org/10.1158/1078-0432.c.6528884.v1
https://doi.org/10.1158/1078-0432.c.6528884.v1
Autor:
Eric C. Kauffman, Charles L. Roche, Michael Petroziello, Craig Hendler, Thomas Schwaab, Kristopher M. Attwood, Christine Murekeyisoni, Daniel Abbotoy, Terrance T. Creighton, Shervin Badkhshan, Bo Xu, Jay Amin
Eosinophilia in ChRCC tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50e37693843e1f0bd79ac624db325245
https://doi.org/10.1158/1078-0432.22474712
https://doi.org/10.1158/1078-0432.22474712
Autor:
Eric C. Kauffman, Charles L. Roche, Michael Petroziello, Craig Hendler, Thomas Schwaab, Kristopher M. Attwood, Christine Murekeyisoni, Daniel Abbotoy, Terrance T. Creighton, Shervin Badkhshan, Bo Xu, Jay Amin
Representative examples of CD117 and CK immunostaining in ChRCC and RO tumors. Representative staining images are shown at 100X magnification. (A-B) Hematoxylin & Eosin staining for (A) ChRCC and (B) RO. (C-D) Typical strong/diffuse CD117 staining in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d456e0f5052e36dd9aaafa35325cf58
https://doi.org/10.1158/1078-0432.22474715
https://doi.org/10.1158/1078-0432.22474715
Autor:
Clemency BM; Department of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Buffalo, NY., Lynch JJ; Department of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Buffalo, NY., Creighton T; Detroit Medical Center, Detroit, MI., Lindstrom HA; Department of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Buffalo, NY.
Publikováno v:
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine [Acad Emerg Med] 2019 Aug; Vol. 26 (8), pp. 944-945. Date of Electronic Publication: 2019 Jun 11.
Autor:
Hanzly M; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA. daniel.abbotoy@roswellpark.org.; Department of Urology, Buffalo Medical Group, Orchard Park, NY, USA. daniel.abbotoy@roswellpark.org., Abbotoy D; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Creighton T; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Diorio G; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Mehedint D; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Murekeyisoni C; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Attwood K; Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY, USA., Kauffman E; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Fabiano AJ; Department of Neurosurgery, Roswell Park Cancer Institute, Buffalo, NY, USA., Schwaab T; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA.
Publikováno v:
Clinical & experimental metastasis [Clin Exp Metastasis] 2015 Dec; Vol. 32 (8), pp. 783-8. Date of Electronic Publication: 2015 Oct 07.
Autor:
Hanzly M; 1 Department of Urology, Roswell Park Cancer Institute , Buffalo, New York., Frederick A, Creighton T, Atwood K, Mehedint D, Kauffman EC, Kim HL, Schwaab T
Publikováno v:
Journal of endourology [J Endourol] 2015 Mar; Vol. 29 (3), pp. 297-303. Date of Electronic Publication: 2014 Oct 21.
Autor:
Hanzly M; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Creighton T; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Mix M; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Zeeck K; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Fung-Kee-Fung S; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Singh AK; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA., Schwaab T; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA.
Publikováno v:
Urology case reports [Urol Case Rep] 2014 Jun 28; Vol. 2 (5), pp. 147-9. Date of Electronic Publication: 2014 Jun 28 (Print Publication: 2014).
Autor:
Aboumohamed AA; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY., Raza SJ; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY., Al-Daghmin A; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY., Tallman C; Department of Urology, University of Michigan, Ann Arbor, MI., Creighton T; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY., Crossley H; Department of Urology, University of Michigan, Ann Arbor, MI., Dailey S; Department of Urology, University of Michigan, Ann Arbor, MI., Khan A; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY., Din R; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY., Mehedint D; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY., Wang K; Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY., Shi Y; Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY., Sharif M; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY., Wilding G; Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY., Weizer A; Department of Urology, University of Michigan, Ann Arbor, MI., Guru KA; Department of Urology, Roswell Park Cancer Institute, Buffalo, NY. Electronic address: khurshid.guru@roswellpark.org.
Publikováno v:
Urology [Urology] 2014 Jun; Vol. 83 (6), pp. 1300-8. Date of Electronic Publication: 2014 Apr 18.